Aleutian Capital Group (“Aleutian Capital”), a New York-based middle-market investment bank, is pleased to announce the successful acquisition of VaLogic, LLC by 424 Capital. Aleutian Capital originated the opportunity. Terms of the transaction were not publicly disclosed.
About VaLogic, LLC
VaLogic is a reliable and trusted partner for GxP compliance. VaLogic offers a wide range of services, including calibration, CQV (Commissioning, Qualification, and Validation), environmental monitoring, and certification. The specialization in pharmaceuticals, biotechnology, and life sciences ensures guaranteed unwavering compliance, operational efficiency, and excellence. For more information on VaLogic, please visit www.valogicbio.com.
About 424 Capital
424 Capital is a capital partner that invests in lower middle market companies in the tech enabled services space. 424 Capital works in partnership with founders and management teams to accelerate and scale for long-term growth. 424 invests in, empowers, and enables companies to step up, stand out, and make a difference in the world. For more information about 424 Capital, please visit www.424capital.com.